Clinical Trials Logo

Myopia clinical trials

View clinical trials related to Myopia.

Filter by:

NCT ID: NCT05597397 Recruiting - Myopia Clinical Trials

Effect of Repeated Low-Level Red-Light Therapy on Retinal Function and Structure

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this clinical trial is to evaluate the effect of repeated low-level red-light (RLRL) therapy on the retinal function and structure among myopic teenagers.

NCT ID: NCT05597163 Not yet recruiting - Myopia, Progressive Clinical Trials

Efficacy and Safety of Low-concentration Atropine for Myopia Control in Chinese Children and Adolescents

LAMC
Start date: January 15, 2023
Phase: N/A
Study type: Interventional

To investigate the efficacy and safety of three low-concentration atropine sulfate eye drops (0.01%, 0.025% and 0.05%) in controlling the progression of myopia in Chinese children and adolescents through a two-year clinical trial.

NCT ID: NCT05594732 Completed - Myopia Clinical Trials

The Effects of Different Outdoor Light Exposure Modes on Retinal Blood Flow

Start date: September 6, 2022
Phase: N/A
Study type: Interventional

In 2020, the overall myopia rate among children and adolescents in my country was 52.7%. The COVID-19 pandemic has increased students' time of indoor eye-using, and it showed that the light exposure intensity of myopic students is lower than that of non-myopia students. Studies have found that the light wave bandwidth has a significant impact on the emmetropization of the eye, and white light can promote emmetropia more than monochromatic light. It shows that outdoor exercise has a protective effect on the occurrence and development of myopia in children and adolescents, but the specific mechanism is still unclear. Retinal blood flow is sensitive to myopic stimuli, and is a short-term indicator of the relationship between light environment and myopia. This study selected retinal blood flow as the primary outcome, aiming to compare the effects of different outdoor light exposure modes on retinal blood flow after 1 hour of intense eye use, and provide clues for the prevention and control of myopia.

NCT ID: NCT05594719 Recruiting - Myopia Clinical Trials

The Effect of Sun-like Spectrum With Different Spectrum Composition on Retinal Blood Flow

Start date: September 6, 2022
Phase: N/A
Study type: Interventional

In 2020, the overall myopia rate among children and adolescents was 52.7% in China. The COVID-19 pandemic has increased students' time of indoor eye-using, and it showed that the light exposure intensity of myopic students is lower than that of non-myopia students. Studies have found that in addition to exposure to light intensity, the occurrence and development of myopia is also related to the color temperature and wavelength band of light. The sun-like spectrum refers to the spectrum with continuous wavelength bands. Animal experiments suggest that sun-like artificial lighting can prevent myopia, but the relationship between sun-like artificial lighting with different color temperatures and myopia is unknown. Clinical trials suggest that artificial lighting with a sun-like spectrum can delay fundus blood flow decline. One hypothesis is that reduced choroidal blood flow leads to scleral hypoxia and promotes the development of myopia. This study aims at comparing the effects of sun-like spectrum artificial lighting with different dominant wavelengths on the human eye, and providing clues for the prevention and control of myopia.

NCT ID: NCT05594537 Not yet recruiting - Cataract Clinical Trials

The Best Way to Improve the Near Visual Acuity After ZXR00 IOL Implantation

Start date: November 1, 2022
Phase:
Study type: Observational

The Best Way to Improve the Near Visual Acuity After ZXR00 IOL Implantation

NCT ID: NCT05588882 Active, not recruiting - Myopia Clinical Trials

Wavefront-guided vs. Topography-guided LASIK

Start date: October 19, 2022
Phase: N/A
Study type: Interventional

The study is comparing outcomes of wavefront-guided LASIK to topography-guided LASIK in a randomized contralateral fellow eye study in myopic participants.

NCT ID: NCT05588362 Not yet recruiting - Myopia Clinical Trials

Access to EyeGlasses for School-aged Children

ATEG
Start date: February 1, 2023
Phase: N/A
Study type: Interventional

Uncorrected refractive error is a leading cause of visual impairment in children and can impact vision, quality of life, and academic performance. Despite Boston Children's Hospital serving patients from a wide range of socioeconomic backgrounds, there are health disparities in access to eyeglasses as a consequence of patients' health insurance. The investigators will examine whether the use of an in-clinic app for 3-D printed glasses reduces disparities in access to eyeglasses for our patients on Medicaid. The intervention will address social determinants of health and improve pediatric health outcomes namely, how and when children having publicly funded health insurance receive eyeglasses. The short-term objectives are (1) to compare the time to receive glasses between publicly funded MassHealth eyeglasses and an in-clinic order of 3D printed glasses (2) to evaluate compliance with glasses wear in these two groups, and (3) to evaluate visual function and quality-of-life outcomes in these two groups. This prospective randomized control study will evaluate barriers to accessing eyeglasses in school-aged children. The investigators will recruit children enrolled in MassHealth and randomize them into two cohorts: (1) the control group will receive MassHealth glasses as per standard of care, through an optical shop of their choosing, or (2) the intervention group will use an app for immediately ordering glasses (paid for by the study) in clinic following their appointment. The investigators will evaluate the time needed to receive eyeglasses, compliance with glasses wear, quality of life, and visual outcomes between the cohorts at one-, three-, and six-month intervals. Through this project, the investigators will not only evaluate, quantify, and bring awareness to disparities in our patient population, but will also look toward finding a solution through the use of a novel application that addresses many of the barriers faced by patients insured through Medicaid.

NCT ID: NCT05562622 Active, not recruiting - Myopia Clinical Trials

Assessment of DOT Spectacles in Chinese Children

CATHAY
Start date: February 5, 2023
Phase: N/A
Study type: Interventional

This is a randomized, controlled, evaluator-blinded, multicenter, two-arm parallel group clinical trial of 12-months duration to evaluate the continued safety and efficacy of Diffusion Optics Technology (DOT) spectacle lenses by comparing to single vision, impact-resistant spectacle lenses in reducing the progression of juvenile myopia in children of Chinese origin.

NCT ID: NCT05562336 Not yet recruiting - Clinical trials for Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia

Optical Coherence Tomography Angiography Criteria Of The Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia (Comparative Study).

Start date: October 2022
Phase:
Study type: Observational

This study aims to compare choroidal neo-vascular membrane criteria in cases of age-related macular degeneration and cases of pathological myopia.

NCT ID: NCT05559567 Not yet recruiting - Myopia Clinical Trials

Axial Length With Adult Onset Myopia (ALWAOM)

ALWAOM
Start date: September 2022
Phase: N/A
Study type: Interventional

Purpose: To determine axial length progression and its relationship with myopia onset and progression in adults.